Growth In The Automated Analyzers Market Is Driven By Rising Chronic Disease Prevalence Supporting Market Expansion
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Will The Market Value Of The Automated Analyzers Market Grow Between 2026 And 2030?
The automated analyzers market size has experienced strong growth in recent years. It is projected to increase from $5.39 billion in 2025 to $5.79 billion in 2026, at a compound annual growth rate (CAGR) of 7.4%. The expansion observed historically can be attributed to manual and semi-automated testing methods, limited laboratory workforce efficiency, increasing clinical testing volumes, the growth of diagnostic laboratories, and reliance on conventional analyzers.
The automated analyzers market is projected to experience robust expansion in the coming years. This market is anticipated to reach a valuation of $7.6 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.0%. Factors contributing to this growth during the forecast period include enhancements in fully automated analyzers, their integration with AI and big data analytics, an increasing need for rapid diagnostics, the ongoing expansion of genomics and proteomics research, and the wider adoption of point-of-care testing solutions. Key trends defining the forecast period involve the growing implementation of automated laboratory systems, an escalating demand for high-throughput sample processing, the incorporation of multi-functional analyzers within laboratory settings, an expansion in clinical diagnostics and research applications, and improvements in the accuracy and standardization of analytical testing.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19322&type=smp
Which Factors Are Influencing The Growth Of The Automated Analyzers Market?
The increasing occurrence of chronic illnesses is anticipated to fuel the expansion of the automated analyzers market in the coming years. This surge in chronic disease prevalence globally stems from factors like aging populations, unhealthy lifestyles, and increased urbanization. Automated analyzers are integral to chronic disease management, providing efficient and accurate diagnostic testing that enables early detection, monitoring, and treatment of conditions such as diabetes, cardiovascular diseases, and kidney disorders. For instance, in June 2023, a report published by Kidney Research UK, a UK-based non-profit organization, stated that approximately 7.2 million people in the UK are living with chronic kidney disease, accounting for over 10% of the population. Among these, 3.25 million are in the advanced stages of the disease, with an additional 3.9 million in the early stages. By 2033, the number of individuals affected by chronic kidney disease is projected to rise to 7.61 million. Thus, the growing prevalence of chronic diseases is propelling the growth of the automated analyzers market.
What Segment Categories Shape The Automated Analyzers Market Segment Landscape?
The automated analyzers market covered in this report is segmented –
1) By Type: Biochemistry Analyzers, Immuno-Based Analyzers, Hematology Analyzers, Other Types
2) By Sample Type: Blood, Urine, Serum, Plasma, Other Sample Types
3) By Application: Drug Discovery, Genomics, Proteomics, Bio Analysis, Clinical Diagnostics, Other Applications
4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Pharmaceutical And Biotechnology Companies, Other End Users
Subsegments:
1) By Biochemistry Analyzers: Clinical Biochemistry Analyzers, Point-of-Care Biochemistry Analyzers, Integrated Biochemistry Systems
2) By Immuno-Based Analyzers: Immunoassay Analyzers, Enzyme-Linked Immunosorbent Assay (ELISA) Analyzers, Chemiluminescent Immunoassay (CLIA) Analyzers
3) By Hematology Analyzers: Automated Hematology Analyzers, Flow Cytometry-Based Hematology Analyzers, Complete Blood Count (CBC) Analyzers
4) By Other Types: Molecular Analyzers, Urinalysis Analyzers, Coagulation Analyzers
Which Trends Are Influencing Demand In The Automated Analyzers Market?
Leading companies in the automated analyzers market are concentrating on developing innovative solutions, such as automated clinical chemistry analyzers, to elevate efficiency, accuracy, and processing capacity in diagnostic laboratories. These automated clinical chemistry analyzers are sophisticated instruments utilized in labs to perform a wide array of chemical tests on blood and other bodily fluids with minimal human involvement, thereby enhancing the speed and correctness of diagnostic testing. For instance, in January 2024, Beckman Coulter, a US-based manufacturing company, introduced the DxC 500 AU Chemistry Analyzer, representing a significant advancement in automated clinical chemistry. Equipped with over 120 high-quality assays, this analyzer is engineered to considerably enhance the capabilities of satellite and independent community hospital labs. It integrates advanced automation, streamlined workflows, and standardized reagents to boost testing efficiency and support clinical decision-making. By serving as an essential complement to central hub laboratories within healthcare systems employing hub-and-spoke models, the DxC 500 AU improves overall efficiency and expands access to vital testing services.
Who Are The Companies Operating Across The Automated Analyzers Market Value Chain?
Major companies operating in the automated analyzers market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Honeywell International, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Tosoh Corporation, Agilent Technologies Inc., Grifols S.A., Xylem Inc., Hitachi High-Tech Corporation, Mindray, PerkinElmer Inc, bioMérieux SA, Sysmex Corporation, Bruker Corporation, Horiba Medical, Randox Laboratories Ltd., Nova Biomedical Corporation, Trinity Biotech Plc
Get The Full Automated Analyzers Market Report:
https://www.thebusinessresearchcompany.com/report/automated-analyzers-global-market-report
Where Is The Automated Analyzers Market Most Concentrated Geographically?
North America was the largest region in the automated analyzers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated analyzers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Automated Analyzers Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=19322&type=smp
Browse Through More Reports Similar to the Global Automated Analyzers Market 2026, By The Business Research Company
Hematology Analyzers And Reagents Market Report 2026
Blood Gas And Electrolyte Analyzers Market Report 2026
Veterinary Hematology Analyzers Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
